A Role for Ubiquitin Binding in Bcr-Abl Transformation

Abstract

We have previously identified a docking site for ubiquitin in the amino-terminus of p210 BCR/ABL. In this proposal we have examined whether this association has implications for BCR/ABL signaling and transforming activity. Our approach was to map the binding site for ubiquitin in BCR/ABL and generate a binding mutant. The binding site is immediately adjacent to the GRB2 binding site, but the two binding activities are genetically separable. Although ubiquitin binding does not regulate BCR/ABL tyrosine kinase activity, the mutant can no longer interact with phosphorylated beta-catenin suggesting that BCR/ABL interacts with beta-catenin in a ubiquitin-dependent manner. A BCR/ABL mutant that cannot bind ubiquitin, but can still interact with Grb2, was tested for transforming activity in murine myeloid cells. The mutant can still support IL-3 independent growth in these cells indicating that some, but not all BCR/ABL activities are dependent upon this association.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2009
Accession Number
ADA510762

Entities

People

  • Ian P. Whitehead

Organizations

  • University of Medicine and Dentistry of New Jersey

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Amino Acids Peptides And Proteins
  • Anatomy
  • Antibodies
  • Biological Sciences
  • Biomedical Research
  • Biomolecules
  • Cell Line
  • Cells
  • Kinases
  • Medical Personnel
  • Mutant Proteins
  • Myeloid Cells
  • New Jersey
  • Proteins
  • Students
  • Tyrosine

Fields of Study

  • Biology
  • Computer science

Readers

  • Breast cancer cell signaling and growth regulation.
  • Immunology

Technology Areas

  • Biotechnology